NEW YORK – ALPCO-GeneProof said on Thursday it is partnering with Revvity subsidiary Euroimmun for the distribution of dozens of GeneProof PCR kits throughout the European Union.

纽约——ALPCO GeneProof周四表示，它正在与Revivity子公司Euroimmun合作，在整个欧盟范围内分发数十种GeneProof PCR试剂盒。

The firms said that the deal will use Euroimmun's distribution network and support infrastructure to broaden the reach of a portfolio of 42 GeneProof PCR assays. Financial and other terms of the deal were not disclosed.

两家公司表示，该交易将利用Euroimmun的分销网络和支持基础设施，扩大42种基因验证PCR检测组合的覆盖范围。交易的财务和其他条款未披露。

The ALPCO-GeneProof assays are used for the identification of infectious diseases and antibiotic-resistant infections as well as to aid the treatment of transplant and immunocompromised patients, the firms said. The tests also incorporate technologies that are intended to provide for simplified workflows and compatibility across a broad range of qPCR instruments..

这些公司表示，ALPCO基因检测用于鉴定传染病和抗生素耐药性感染，以及帮助治疗移植和免疫功能低下的患者。这些测试还结合了旨在简化工作流程和兼容各种qPCR仪器的技术。。

'Having Euroimmun as a partner brings a strong focus to the European Union for the GeneProof products,' ALPCO-GeneProof CEO Erik Allen said in a statement. 'Combining our high-quality IVDR-cleared kits with their expertise in the diagnostic space and strong commercial presence means more customers can access the fast-growing GeneProof infectious disease assays.'.

ALPCO GeneProof首席执行官埃里克·艾伦（ErikAllen）在一份声明中说，拥有Euroimmun作为合作伙伴，欧盟将重点关注基因保护产品将我们的高质量IVDR清除试剂盒与他们在诊断领域的专业知识和强大的商业存在相结合，意味着更多的客户可以获得快速增长的基因抗感染性疾病检测。”。